Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial
暂无分享,去创建一个
D. Kass | L. DiCarlo | S. Krueger | A. Feldman | L. Saxon | J. Boehmer | M. Bristow | P. Carson | E. Galle | Fred Ecklund | T. Marco | F. Ecklund
[1] David L Hayes,et al. Sustained Reverse Left Ventricular Structural Remodeling With Cardiac Resynchronization at One Year Is a Function of Etiology: Quantitative Doppler Echocardiographic Evidence From the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) , 2006, Circulation.
[2] W. Stevenson,et al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. , 1989, Circulation.
[3] A. Kadish,et al. DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE). , 2003, Cardiac electrophysiology review.
[4] A. Moss,et al. Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator , 2004, Circulation.
[5] A. Moss,et al. Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction , 2004, Circulation.
[6] Andrew P. Kramer,et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. , 2003, Journal of the American College of Cardiology.
[7] D. Delurgio,et al. Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.
[8] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[9] R. Foley,et al. Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] C Cates,et al. Confidence intervals for the number needed to treat , 1999 .
[11] E. Foster,et al. Effects of Long-Term Biventricular Stimulation for Resynchronization on Echocardiographic Measures of Remodeling , 2002, Circulation.
[12] B. Wilkoff,et al. Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients , 2004, Journal of cardiovascular electrophysiology.
[13] Hugh Calkins,et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.
[14] D. Alter,et al. The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefits. , 2006, Journal of evaluation in clinical practice.
[15] P. McCullough,et al. Impact of Chronic Kidney Disease Upon Survival Among Implantable Cardioverter-Defibrillator Recipients , 2004, Journal of Interventional Cardiac Electrophysiology.
[16] Paul J. Wang,et al. Heart Failure and the Risk of Shocks in Patients With Implantable Cardioverter Defibrillators: Results From the Triggers Of Ventricular Arrhythmias (TOVA) Study , 2004, Circulation.
[17] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.
[18] Christophe Leclercq,et al. Regional Alterations in Protein Expression in the Dyssynchronous Failing Heart , 2003, Circulation.
[19] J. Ruskin,et al. Clinical Course and Implantable Cardioverter Defibrillator Therapy in Postinfarction Women with Severe Left Ventricular Dysfunction , 2005, Journal of cardiovascular electrophysiology.
[20] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[21] R. Canby,et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.
[22] C. O'connor,et al. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. , 2005, Journal of the American College of Cardiology.
[23] E. Foster,et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. , 2003, Journal of the American College of Cardiology.
[24] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.